EVAX Evaxion A/S

NASDAQ
$3.34

Evaxion A/S (EVAX) is expected to report earnings on November 2, 2026, before the market open. The stock has had a Post-Earnings Announcement Drift (PEAD) of -1.8% since its last earnings release on August 20, 2026.

Evaxion A/S Reported Earnings
Thursday, August 20, 2026 · 7:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 2
Monday · 7:30 AM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $3.26

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Evaxion A/S

Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.